Canine glaucoma medically, although sometimes surgery is required. As the cause of primary glaucoma is often unknown, medical treatment is usually aimed at reducing the main sign of glaucoma (raised intraocular pressure) rather than at treating the cause of the disease. The aim of surgery in dogs with glaucoma is to reduce intraocular pressure. This is achieved by reducing aqueous humor production, or by improving drainage of aqueous humor from the eye. Laser surgery is often performed to selectively destroy the tissue, ciliary body, in an effort to reduce aqueous fluid production. Laser surgery can also be combined with placement of a
Minimally invasive glaucoma surgery vision and take extra time to recover. The surgery site can scar over time and the pressure can go back up. In early 2014, the NeoMedix received a warning letter from FDA regarding marketing practices. Minimally invasive glaucoma surgery Micro-invasive glaucoma surgery (MIGS) is the latest advance in surgical treatment for glaucoma, which aims to reduce intraocular pressure by either increasing outflow of aqueous humor or reducing its production. MIGS comprises a group of surgical procedures which share common features. MIGS procedures involve a minimally invasive approach, often with small cuts or micro-incisions through the cornea that causes the least